1 – 10 of 122
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
- Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer
- Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey
- Integrated models for the prediction of late genitourinary complaints after high-dose intensity modulated radiotherapy for prostate cancer: making informed decisions
- 2013
- Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome
- Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients
- Radiation-induced myosin IIA expression stimulates collagen type I matrix reorganization
- Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions
- Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT
- Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT): dosimetrical analysis and effect on acute toxicity
- A predictive model for dysphagia following IMRT for head and neck cancer: introduction of the EMLasso technique